Expression of Ryanodine Receptor mRNA and Sarcoplasmic Ca2+-ATPase mRNA in the Myocardium and Intracellular Reorganization of Cardiomyocytes in Dyslipidemia and during Verapamil Treatment

Verfasser / Beitragende:
[E. Yuzhik, E. Lushnikova, M. Klinnikova, V. Pichigin, L. Nepomnyashchikh]
Ort, Verlag, Jahr:
2015
Enthalten in:
Bulletin of Experimental Biology and Medicine, 158/4(2015-02-01), 544-550
Format:
Artikel (online)
ID: 605538069
LEADER caa a22 4500
001 605538069
003 CHVBK
005 20210128100900.0
007 cr unu---uuuuu
008 210128e20150201xx s 000 0 eng
024 7 0 |a 10.1007/s10517-015-2804-1  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10517-015-2804-1 
245 0 0 |a Expression of Ryanodine Receptor mRNA and Sarcoplasmic Ca2+-ATPase mRNA in the Myocardium and Intracellular Reorganization of Cardiomyocytes in Dyslipidemia and during Verapamil Treatment  |h [Elektronische Daten]  |c [E. Yuzhik, E. Lushnikova, M. Klinnikova, V. Pichigin, L. Nepomnyashchikh] 
520 3 |a In experiments on rats, atherogenic diet led to hypercholesterolemia, while addition of verapamil to the diet led to the development of hypertriglyceridemia in these animals. Dyslipidemia induced signifi cant changes in the cardiomyocyte ultrastructure (lytic changes in myofi brils and sarcoplasmic matrix and aggravation of autophagocytosis) that were most pronounced after addition of mercazolyl alone to the diet. After 30-day atherogenic diet, we observed a decrease in the relative content of RyR2 mRNA (by 67-73%, p<0.01) and SERCA2a mRNA (by 75-91%, p<0.01) in the myocardium. In 64 days these parameters remained reduced: by 64-72% (p<0.05) and 54-62% (p<0.05), respectively. Verapamil treatment reduced the severity and number of lytic lesions in cardiomyocytes, induced considerable glycogen accumulation in the sarcoplasm and its sequestration, promoted normalization, and prevented pronounced decrease of the relative RyR2 mRNA and SERCA2a mRNA in rat myocardium. 
540 |a Springer Science+Business Media New York, 2015 
690 7 |a dyslipidemia  |2 nationallicence 
690 7 |a cardiomyocyte ultrastructure  |2 nationallicence 
690 7 |a verapamil  |2 nationallicence 
690 7 |a Ca 2+ transport  |2 nationallicence 
690 7 |a electron microscopy  |2 nationallicence 
700 1 |a Yuzhik  |D E.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
700 1 |a Lushnikova  |D E.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
700 1 |a Klinnikova  |D M.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
700 1 |a Pichigin  |D V.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
700 1 |a Nepomnyashchikh  |D L.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
773 0 |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/4(2015-02-01), 544-550  |x 0007-4888  |q 158:4<544  |1 2015  |2 158  |o 10517 
856 4 0 |u https://doi.org/10.1007/s10517-015-2804-1  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10517-015-2804-1  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Yuzhik  |D E.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Lushnikova  |D E.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Klinnikova  |D M.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Pichigin  |D V.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nepomnyashchikh  |D L.  |u Research Institute of Regional Pathology and Pathomorphology, Siberian Division of the Russian Academy of Medical Sciences, Novosibirsk, Russia  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Bulletin of Experimental Biology and Medicine  |d Springer US; http://www.springer-ny.com  |g 158/4(2015-02-01), 544-550  |x 0007-4888  |q 158:4<544  |1 2015  |2 158  |o 10517